Paul Tudor Jones’s Encompass Health EHC Stock Holding History

Paul Tudor Jones’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,045	Closed	-$482K	–	2563
2021 Q3	$482K	Buy	+8,045	New	+$506K	0.01%	1680

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Paul Tudor Jones's EHC Position: Q2 2026 in Review

Paul Tudor Jones sold out of Encompass Health (EHC) in Q2 2026, closing a stake of 30,730 shares — an estimated $2.97M sold.

Paul Tudor Jones first reported a position in EHC in Q2 2013 and held it in 36 quarters. The position peaked at $34.5M in Q4 2025. 594 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

Paul Tudor Jones reported no remaining Encompass Health position as of Q2 2026 after selling out during the quarter.
Paul Tudor Jones sold 30,730 Encompass Health shares in Q2 2026, an estimated $2.97M.
Paul Tudor Jones first reported a position in Encompass Health in Q2 2013 and held it in 36 quarters.
Paul Tudor Jones's Encompass Health position peaked at $34.5M in Q4 2025.
594 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.